Instituto COI de Pesquisa Educacao e Gestao (Site 0825)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Liver and biliary tract cancer

Closed trials

• Completed

  Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

  NCT03867084· Phase 3· Merck Sharp & Dohme LLC· Source